Change 5-day change 1-year change 3-year change Capi.($)
-.--%+3.58% - - 0
-0.04%-1.40%+57.16%+108.15% 1,034B
+1.17%+4.76%+56.42%+73.50% 671B
-0.58%+0.80%+22.82%+75.58% 460B
-0.41%-0.84%+29.02%+38.06% 353B
-1.09%+5.08%+25.12%+46.04% 309B
-0.29%+1.49%-0.33%+13.64% 255B
+0.29%+1.63%+56.46%+73.00% 240B
-0.64%+1.44%-16.85%-54.26% 207B
+1.08%+1.59%+33.83%+97.29% 188B
Average -0.60%+1.27%+29.30%+52.33% 412.97B
Weighted average by Cap. -0.68%+1.04%+38.14%+67.67%
Logo Shire PLC
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-